DCTH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Delcath Systems Inc (DCTH) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are neutral to bearish, the options data suggests a bearish sentiment, and while the company has shown strong revenue growth, its net income and EPS have significantly declined. Additionally, there are no recent positive news catalysts or significant insider/congress trading activity to support a buy decision. Analysts remain positive with a raised price target, but the lack of immediate strong signals and the bearish short-term trend make this stock better suited for monitoring rather than immediate investment.
The MACD is below 0 and negatively contracting, RSI is neutral at 48.492, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 9.022, resistance at 10.091. Short-term stock trend analysis predicts a -0.46% change in the next week and -7.93% in the next month.
Analyst rating remains positive with a raised price target to $29, citing steady contributions from Hepzato and predictable quarter-to-quarter variability.
No significant trading trends from hedge funds or insiders. No recent news or congress trading activity. Short-term stock trend analysis predicts a negative price movement in the coming weeks.
In Q3 2025, revenue increased by 83.60% YoY to $20,563,000, but net income dropped by 55.47% YoY to $830,000, and EPS fell by 66.67% YoY to 0.02. Gross margin improved slightly to 87.24%, up 2.20% YoY.
Clear Street raised the price target to $29 from $28 and maintained a Buy rating, citing steady contributions from Hepzato and predictable growth.
